Integrated Continuous Manufacturing Position CONTINUUS as a pioneer in Integrated Continuous Manufacturing ICM to modernize pharma production; identify opportunities to partner on contract development and manufacturing for small molecules and oncology drugs seeking improved lead times and cost efficiency.

Global affordability focus Leverage their mission to lower drug costs and increase accessibility to pursue collaborations with generic, biotech, and government programs aiming to reduce healthcare expenses and address drug shortages in critical therapeutic areas.

Strategic partnerships Target potential customers and collaborators who value advanced manufacturing platforms, including pharmaceutical developers, contract manufacturers, and defense or DoD-related medical supply programs, given existing DoD interest and large-scale facility ambitions.

Recent growth signals Capitalize on recent leadership addition to the board and past facility development deals as evidence of scale-up capability; propose engagement around pilot programs, facility expansion, or technology licensing to accelerate customer time-to-market.

Early stage funding leverage Use their modest revenue and early-stage funding profile to position as a growth partner for early- to mid-stage drug programs that need scalable continuous manufacturing solutions before large-scale commercial readiness.